Purchases and Sales Made in Q2 2022 in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE) during Q2 2022. The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-190K- 41.23% |
$531K - $1.45M
|
270K
$0
|
|
|
Jul 25, 2022
Q2 2022
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-248KClosed |
$695K - $1.9M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-322K- 6.88% |
$902K - $2.47M
|
4.36M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-499K- 33.71% |
$1.4M - $3.83M
|
982K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-814KClosed |
$2.28M - $6.24M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-1.4MClosed |
$3.92M - $10.7M
|
0
$0
|